Neurotransmitter transporters as molecular targets for addictive drugs
- 18 June 1998
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 51 (1-2) , 87-96
- https://doi.org/10.1016/s0376-8716(98)00068-4
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- N-Linked Oligosaccharides Are Required for Cell Surface Expression of the Norepinephrine Transporter but Do Not Influence Substrate or Inhibitor RecognitionJournal of Neurochemistry, 2002
- Individual Residues Contribute to Multiple Differences in Ligand Recognition between Vesicular Monoamine Transporters 1 and 2Journal of Biological Chemistry, 1997
- Charged Residues in Transmembrane Domains II and XI of a Vesicular Monoamine Transporter Form a Charge Pair That Promotes High Affinity Substrate RecognitionPublished by Elsevier ,1997
- Chimeric Vesicular Monoamine Transporters Identify Structural Domains That Influence Substrate Affinity and Sensitivity to TetrabenazinePublished by Elsevier ,1996
- Antipeptide Antibodies Confirm the Topology of the Human Norepinephrine TransporterJournal of Biological Chemistry, 1995
- Dopamine Transporter Cysteine Mutants: Second Extracellular Loop Cysteines Are Required for Transporter ExpressionJournal of Neurochemistry, 1995
- A Molecular Glimpse of Vesicular Monoamine TransportersJournal of Neurochemistry, 1994
- Permeation Properties of Neurotransmitter TransportersAnnual Review of Pharmacology and Toxicology, 1994
- Cloning and expression of the vesamicol binding protein from the marine ray TorpedoFEBS Letters, 1994
- Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytesNeuron, 1993